Edward T. H. Yeh
#132,948
Most Influential Person Now
Edward T. H. Yeh's AcademicInfluence.com Rankings
Edward T. H. Yehphilosophy Degrees
Philosophy
#6558
World Rank
#9613
Historical Rank
Logic
#3708
World Rank
#4906
Historical Rank
Edward T. H. Yehbiology Degrees
Biology
#8902
World Rank
#12040
Historical Rank
Molecular Biology
#1165
World Rank
#1191
Historical Rank
Biochemistry
#1316
World Rank
#1436
Historical Rank
Download Badge
Philosophy Biology
Edward T. H. Yeh's Degrees
- Doctorate Medicine Harvard University
Why Is Edward T. H. Yeh Influential?
(Suggest an Edit or Addition)Edward T. H. Yeh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells (2000) (2015)
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity (2012) (1396)
- Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. (2009) (1088)
- Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs (2001) (877)
- Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 (1999) (842)
- Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. (2004) (780)
- Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. (2000) (546)
- Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells (2003) (540)
- Radiation-related heart disease: current knowledge and future prospects. (2010) (524)
- Ubiquitin-like proteins: new wines in new bottles. (2000) (514)
- p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. (2001) (504)
- SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during Hypoxia (2007) (499)
- Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. (2014) (487)
- Transdifferentiation of Human Peripheral Blood CD34+-Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo (2003) (452)
- A tale of two diseases: atherosclerosis and rheumatoid arthritis. (1999) (429)
- SUMOylation and De-SUMOylation: Wrestling with Life's Processes* (2009) (420)
- Characterization of NEDD8, a Developmentally Down-regulated Ubiquitin-like Protein* (1997) (419)
- Coming of age of C-reactive protein: using inflammation markers in cardiology. (2003) (414)
- SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. (2007) (358)
- Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. (1996) (331)
- Identification of Three Major Sentrinization Sites in PML* (1998) (330)
- Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal–Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase Pathways (2004) (320)
- Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. (2005) (303)
- Differential Regulation of Sentrinized Proteins by a Novel Sentrin-specific Protease* (2000) (298)
- Identification of the Activating and Conjugating Enzymes of the NEDD8 Conjugation Pathway* (1999) (267)
- Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1. (2017) (256)
- Characterization of a Family of Nucleolar SUMO-specific Proteases with Preference for SUMO-2 or SUMO-3* (2006) (239)
- Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. (2000) (238)
- A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. (2005) (229)
- Covalent Modification of PML by the Sentrin Family of Ubiquitin-like Proteins* (1998) (225)
- Role of desumoylation in the development of prostate cancer. (2006) (218)
- Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases (1998) (210)
- C-reactive protein: linking inflammation to cardiovascular complications. (2001) (210)
- Both Cell Fusion and Transdifferentiation Account for the Transformation of Human Peripheral Blood CD34-Positive Cells Into Cardiomyocytes In Vivo (2004) (202)
- Regulation of DNA repair through deSUMOylation and SUMOylation of replication protein A complex. (2010) (200)
- Ubiquitin-Like Proteins (2013) (198)
- CRP as a mediator of disease. (2004) (197)
- SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. (2010) (197)
- Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2. (2017) (195)
- Preferential Interaction of Sentrin with a Ubiquitin-conjugating Enzyme, Ubc9* (1997) (187)
- SENP3 is responsible for HIF‐1 transactivation under mild oxidative stress via p300 de‐SUMOylation (2009) (184)
- Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone (2008) (183)
- SENP1 Enhances Androgen Receptor-Dependent Transcription through Desumoylation of Histone Deacetylase 1 (2004) (177)
- Preferential Modification of Nuclear Proteins by a Novel Ubiquitin-like Molecule* (1997) (175)
- Regulation of Apoptosis and Cell Cycle Progression by MCL1 (2000) (174)
- Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin‐activating enzyme complex (1999) (174)
- Inhibition of α4 Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to Atherosclerotic Plaques in ApoE-Deficient Mice (1998) (168)
- Cleavage of the C-terminus of NEDD8 by UCH-L3. (1998) (151)
- Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. (1997) (150)
- SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression. (2010) (148)
- Targeting of NEDD8 and Its Conjugates for Proteasomal Degradation by NUB1* (2001) (141)
- Neddylation of a breast cancer-associated protein recruits a class III histone deacetylase that represses NFκB-dependent transcription (2006) (138)
- Emerging paradigms in cardiomyopathies associated with cancer therapies. (2013) (137)
- Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. (2015) (136)
- CRP and the risk of atherosclerotic events (2009) (136)
- TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes (1986) (135)
- Cardiotoxicity induced by chemotherapy and antibody therapy. (2006) (134)
- Characterization of a Second Member of the Sentrin Family of Ubiquitin-like Proteins* (1998) (130)
- Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis (1998) (126)
- C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation. (2003) (123)
- C-Reactive Protein: Structure Affects Function (2004) (119)
- Identification of a Novel Isopeptidase with Dual Specificity for Ubiquitin- and NEDD8-conjugated Proteins* (2000) (117)
- SUMO-specific protease 1 promotes prostate cancer progression and metastasis (2013) (116)
- Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90 (2010) (110)
- Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. (2007) (106)
- The pleiotropic effects of statins (2005) (102)
- Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants. (1991) (101)
- SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation. (2012) (100)
- NUB1, a NEDD8-interacting Protein, Is Induced by Interferon and Down-regulates the NEDD8 Expression* (2001) (96)
- TAP transcription and phosphatidylinositol linkage mutants are defective in activation through the T cell receptor (1988) (95)
- Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. (1999) (95)
- SENP3-mediated De-conjugation of SUMO2/3 from Promyelocytic Leukemia Is Correlated with Accelerated Cell Proliferation under Mild Oxidative Stress* (2010) (95)
- Nucleocytoplasmic Shuttling Modulates Activity and Ubiquitination-Dependent Turnover of SUMO-Specific Protease 2 (2006) (92)
- Structural characterization of the TAP molecule: A phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1 (1986) (91)
- Activation-induced Aggregation and Processing of the Human Fas Antigen* (1997) (91)
- Identification of NEDD8-conjugation site in human cullin-2. (1999) (91)
- SUMO: From Bench to Bedside. (2020) (91)
- SENP1 Induces Prostatic Intraepithelial Neoplasia through Multiple Mechanisms* (2010) (89)
- Targeting Constitutively Activated β1 Integrins Inhibits Prostate Cancer Metastasis (2013) (89)
- Human CD34+ Cells in Experimental Myocardial Infarction: Long-Term Survival, Sustained Functional Improvement, and Mechanism of Action (2010) (88)
- Oncocardiology-Past, Present, and Future: A Review. (2016) (87)
- Heat shock and Cd2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently (2003) (86)
- De-SUMOylation Enzyme of Sentrin/SUMO-Specific Protease 2 Regulates Disturbed Flow–Induced SUMOylation of ERK5 and p53 that Leads to Endothelial Dysfunction and Atherosclerosis (2013) (86)
- High‐sensitivity C‐reactive protein as a risk assessment tool for cardiovascular disease (2005) (84)
- Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Represses Gene Transcription via SUMO Modification (2005) (84)
- SUMOylation and de‐SUMOylation in response to DNA damage (2011) (83)
- A Dominant-negative UBC12 Mutant Sequesters NEDD8 and Inhibits NEDD8 Conjugation in Vivo * (2000) (81)
- Correction of the class H defect in glycosylphosphatidylinositol anchor biosynthesis in Ltk- cells by a human cDNA clone. (1993) (81)
- Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. (1998) (81)
- Regulation of the NEDD8 Conjugation System by a Splicing Variant, NUB1L* (2003) (80)
- Hyper-SUMOylation of the Kv7 Potassium Channel Diminishes the M-Current Leading to Seizures and Sudden Death (2014) (77)
- Induction of the SUMO-specific Protease 1 Transcription by the Androgen Receptor in Prostate Cancer Cells* (2007) (77)
- Induction of SENP1 in Endothelial Cells Contributes to Hypoxia-driven VEGF Expression and Angiogenesis* (2010) (75)
- Vascular complications of selected cancer therapies (2008) (74)
- Therapy Insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy (2008) (74)
- NF-κB induction of the SUMO protease SENP2: A negative feedback loop to attenuate cell survival response to genotoxic stress. (2011) (69)
- Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function. (2015) (67)
- Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches. (2012) (67)
- The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study. (2016) (64)
- Stimulation of T cells via the TAP molecule, a member in a family of activating proteins encoded in the Ly-6 locus. (1987) (61)
- Differential expression of SUMO-specific protease 7 variants regulates epithelial–mesenchymal transition (2012) (61)
- Complexity of ethanolamine phosphate addition in the biosynthesis of glycosylphosphatidylinositol anchors in mammalian cells. (1992) (60)
- Life and death in the cardiovascular system. (1997) (60)
- Differential Regulation of c-Jun-dependent Transcription by SUMO-specific Proteases* (2005) (59)
- PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia (2010) (54)
- Fusion of Human Hematopoietic Progenitor Cells and Murine Cardiomyocytes Is Mediated by &agr;4&bgr;1 Integrin/Vascular Cell Adhesion Molecule-1 Interaction (2007) (54)
- Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond. (2016) (50)
- A cyclic hexapeptide is a potent antagonist of alpha 4 integrins. (1997) (50)
- De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells (2014) (47)
- Identification of a missing link in glycosylphosphatidylinositol anchor biosynthesis in mammalian cells. (1992) (46)
- Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor. (1994) (45)
- Dietary marine lipids suppress continuous expression of interleukin-1β gene transcription1 (2007) (45)
- SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer (2016) (44)
- A new perspective on the biology of C-reactive protein. (2005) (43)
- C-reactive protein: The pawn has been promoted to queen (2003) (38)
- A Critical SUMO1 Modification of LKB1 Regulates AMPK Activity during Energy Stress. (2015) (37)
- SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-β signaling (2018) (36)
- Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step. (1994) (34)
- The expression, function, and ontogeny of a novel T cell-activating protein, TAP, in the thymus. (1986) (34)
- SUMOylated ORC2 Recruits a Histone Demethylase to Regulate Centromeric Histone Modification and Genomic Stability. (2016) (33)
- Molecular Imaging of Mesenchymal Stem Cell: Mechanistic Insight Into Cardiac Repair After Experimental Myocardial Infarction (2012) (33)
- Inhibition of glycosylphosphatidylinositol anchor formation by mannosamine. (1992) (33)
- Induction of SENP1 in myocardium contributes to abnormities of mitochondria and cardiomyopathy. (2015) (32)
- SUMO-specific Protease 1 Regulates Mitochondrial Biogenesis through PGC-1α* (2012) (32)
- Onco-cardiology: the time has come. (2011) (30)
- Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. (1996) (30)
- SENP1 regulates PTEN stability to dictate prostate cancer development (2016) (29)
- The von Hippel-Lindau Tumor Suppressor Gene Product Promotes, but Is Not Essential for, NEDD8 Conjugation to Cullin-2* (1999) (29)
- Fusion of the SUMO/Sentrin-specific protease 1 gene SENP1 and the embryonic polarity-related mesoderm development gene MESDC2 in a patient with an infantile teratoma and a constitutional t(12;15)(q13;q25). (2005) (29)
- An Essential Role of Small Ubiquitin-like Modifier (SUMO)-specific Protease 2 in Myostatin Expression and Myogenesis* (2013) (28)
- Biosynthesis of phosphatidylinositol-glycan (PI-G)-anchored membrane proteins in cell-free systems: PI-G is an obligatory cosubstrate for COOH-terminal processing of nascent proteins. (1992) (28)
- SENP 3 is responsible for HIF-1 transactivation under mild oxidative stress via p 300 de-SUMOylation (2009) (26)
- The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters". (2016) (26)
- A proatherogenic role for C-reactive protein in vivo (2005) (26)
- Chromosomal assignment of genes involved in glycosylphosphatidylinositol anchor biosynthesis: implications for the pathogenesis of paroxysmal nocturnal hemoglobinuria (1994) (26)
- Cancer and Clot: Between a Rock and a Hard Place. (2017) (25)
- DeSUMOylation of MKK7 kinase by the SUMO2/3 protease SENP3 potentiates lipopolysaccharide-induced inflammatory signaling in macrophages (2018) (25)
- Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice. (1987) (25)
- Gene encoding T-cell-activating protein TAP maps to the Ly-6 locus. (1986) (24)
- Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway (2018) (24)
- Chromosomal assignment of genes involved in glycosylphosphatidylinositol anchor biosynthesis: implications for the pathogenesis of paroxysmal nocturnal hemoglobinuria. (1994) (23)
- Subclinical Cardiotoxicity Associated With Cancer Therapy: Early Detection and Future Directions. (2015) (23)
- Analysis of thymocyte MHC specificity with thymocyte hybridomas (1984) (22)
- Identification of novel isoforms of human RAD52. (1999) (22)
- GNB1L, a gene deleted in the critical region for DiGeorge syndrome on 22q11, encodes a G-protein beta-subunit-like polypeptide. (2000) (21)
- Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase (2011) (21)
- A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent. (1997) (21)
- Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin (2020) (21)
- Inhibition of tumor-necrosis-factor-α induced endothelial cell activation by a new class of PPAR-γ agonists : An in vitro study showing receptor-independent effects (2005) (21)
- Biosynthesis and processing of the glycosylphosphatidylinositol anchor in mammalian cells. (1994) (19)
- Report on the International Colloquium on Cardio-Oncology (Rome, 12–14 March 2014) (2014) (19)
- PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. (2009) (18)
- NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis. (2004) (18)
- Human CD 34 Cells in Experimental Myocardial Infarction Long-Term Survival , Sustained Functional Improvement , and Mechanism of Action (2010) (17)
- Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor. (2000) (16)
- sNASP inhibits TLR signaling to regulate immune response in sepsis (2018) (16)
- Suppression of autoimmune disease by ω – 3 fatty acids (1995) (15)
- Stem cells and cardiovascular tissue repair: Mechanism, methods, and clinical applications (2006) (13)
- The in vivo functions of desumoylating enzymes. (2010) (12)
- Weighing in on heart failure: the role of SERCA2a SUMOylation. (2012) (12)
- Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: Beyond cardiovascular diseases (2004) (11)
- Differential expression of glycosylphosphatidylinositol-anchored proteins in a murine T cell hybridoma mutant producing limiting amounts of the glycolipid core. Implications for paroxysmal nocturnal hemoglobinuria. (1992) (10)
- Wrestling with heart failure: SUMO-1 to the rescue. (2014) (10)
- Ubiquitin, proteasome, and restenosis: a brave new world for cardiovascular research. (2002) (10)
- Defective signal transduction in CD4-CD8- T cells of lpr mice. (1989) (8)
- Report from session I the Second International Colloquium on Cardio-oncology, Krakow, Poland: Mechanisms and clinical course of cardiovascular toxicity of cancer treatment (2019) (8)
- Alleviation of Autoimmune Disease by ω3 Fatty Acids (1994) (8)
- Impaired Kv7 channel activity in the central amygdala contributes to elevated sympathetic outflow in hypertension. (2021) (8)
- Expression of T-cell-activating protein in peripheral lymphocyte subsets. (1986) (8)
- Inhibition of (cid:97) 4 Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to Atherosclerotic Plaques in ApoE-Deficient Mice (1998) (7)
- Early detection of cardiotoxicity during chemotherapy using biomarkers (2007) (7)
- Resistin Promotes (2004) (7)
- Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. (2005) (7)
- Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. (2019) (6)
- Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step (1994) (6)
- Blood-derived progenitor cells after recanalization of chronic coronary artery occlusions in humans. (2005) (6)
- Autoimmunity and the pathogenesis of myocarditis. (1994) (6)
- Life and death in the cell (1998) (6)
- Differential effects of endothelin receptor activation on cyclic flow variations in rat mesenteric arteries. (1997) (5)
- Selection of thymocyte MHC restriction specificity in vitro. (1984) (5)
- Publisher Correction: Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway (2018) (5)
- A novel approach to studying transformation of human stem cells into cardiac cells in vivo. (2006) (5)
- What is cardiotoxicity (2014) (5)
- Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight in the global cardiometabolic risk (2007) (4)
- Abnormal T cells from MRL/Mp-lpr/lpr mice do not respond to anti-T-cell-receptor antibody or tumor promoter and calcium ionophore A23187 despite the presence of the T-cell-receptor complex and protein kinase c. (1988) (4)
- Life and death of the cell. (1998) (4)
- Suppression of autoimmune disease by omega-3 fatty acids. (1995) (3)
- Reversible regulation of ORC2 SUMOylation by PIAS4 and SENP2 (2017) (3)
- 972-102 Suppression of ICAM-1 and P-Selectin Adhesion Molecule Expression by Bolus IV Liposomal PGE1 (TLC-C53) Immediately Prior to Reperfusion in a Two Hour Canine Infarct/Reperfusion Model (1995) (3)
- Cardiac complications of cancer treatment (2003) (3)
- C-reactive protein is an essential aspect of cardiovascular risk factor stratification. (2004) (3)
- Cytokine profile and ST-elevation myocardial infarction. (2012) (3)
- Structure and function of the TAP protein and related Ly-6-linked molecules. (1988) (2)
- PEP-sNASP Peptide Alleviates LPS-Induced Acute Lung Injury Through the TLR4/TRAF6 Axis (2022) (2)
- Withdrawal of Heart Failure Medications in Cancer Survivors With Chemotherapy-Induced Left Ventricular Dysfunction: A Pilot Study. (2016) (2)
- Inhibition of Tumor-Necrosis-Factor-αDELETEInduced Endothelial Cell Activation by a New Class of PPAR-γ Agonists (2005) (2)
- SENP2-PLCβ4 signaling regulates neurogenesis through the maintenance of calcium homeostasis (2021) (2)
- Heparin and bone marrow-derived cell therapy: friend or foe? (2012) (2)
- Regulation of TLR4 signaling through the TRAF6/sNASP axis by reversible phosphorylation mediated by CK2 and PP4 (2021) (2)
- Defects in signal transduction caused by a T cell receptor β chain substitution (1990) (2)
- Endotoxin-induced leukocyte accumulation in aqueous fluid of rats is decreased by a small molecule selectin antagonist (1996) (2)
- Inflammation, C-Reactive Protein, and Vulnerable Plaques (2007) (2)
- Molecular Mechanisms of Anthracycline-Induced Cardiotoxicity (2017) (2)
- Response to G. J. Blake and P. M. Ridker: C-reactive protein: a surrogate risk marker or mediator of atherothrombosis? (2003) (2)
- Potential of Oncocardiology-Reply. (2017) (1)
- SUMO-specific Protease 1 is Essential for Stabilization of Hypoxia-inducible factor-1α During Hypoxia (2007) (1)
- Abstract 8: The Membrane-associated Guanylate Kinase Ww and Pdz Domain-containing Protein 1 magi1 is Required for Disturbed Flow-induced Endothelial Inflammation and Atherosclerotic Plaque Formation (2016) (1)
- Signaling pathways involved in NMDA‐induced suppression of M‐channels in corticotropin‐releasing hormone neurons in central amygdala (2022) (1)
- Cancer Therapy-Induced Cardiomyopathy (2013) (1)
- Defects in signal transduction caused by a T cell receptor beta chain substitution. (1990) (1)
- Atherosclerosis Induced SUMOylation of ERK 5 and p 53 that Leads to Endothelial Dysfunction and − De-SUMOylation Enzyme of Sentrin / SUMO-Specific Protease 2 Regulates Disturbed Flow (2013) (1)
- Signal Transduction Targeting Constitutively Activated b 1 Integrins Inhibits Prostate Cancer Metastasis (2015) (1)
- Heart success program: An interdisciplinary patient-centered approach to cancer patients with concurrent heart failure (2015) (1)
- Recovery of chemotherapy-induced left ventricular dysfunction in cancer survivors. (2016) (1)
- T cell-activating protein on murine lymphocytes. (1986) (1)
- Balancing act during development: lessons from a SUMO-less SF-1. (2011) (1)
- Atherosclerotic Plaques in ApoE-Deficient Mice Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to 4 α Inhibition of Print (1998) (1)
- Subject Index Vol. 42, 2005 (2005) (0)
- Human Adipocytes: Linking Obesity to Vascular Inflammation Release of C-Reactive Protein in Response to Inflammatory Cytokines by (2011) (0)
- Human CD34 (cid:1) Cells in Experimental Myocardial Infarction Long-Term Survival, Sustained Functional Improvement, and Mechanism of Action (2010) (0)
- Myostatin Expression and Myogenesis Modifier ( SUMO )-specific Protease 2 in An Essential Role of Small Ubiquitin-like Cell Biology : (2014) (0)
- Abstract 3176: Molecular Imaging of Mesenchymal Stem Cell Following Myocardial Infarction: Evidence for Transdifferentiation (2009) (0)
- Management of Heart Failure Patients with Malignancy (2011) (0)
- SENP1 and SENP2 Peptidases (2013) (0)
- Selection of T cell receptor expression mutants through the functionally linked Ly-6A. (1990) (0)
- C-reactive protein: a surrogate risk marker or mediator of atherothrombosis? Authors' reply (2003) (0)
- Correction: SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-β signaling (2018) (0)
- Cardiac effects of mediator release from tumors (2003) (0)
- Defective Activation by Antigen, Superantigen, and Con A in T Cell Glycosylation Mutants. (1992) (0)
- Abstract 15846: Disturbed Flow-Induced P90RSK Activation Elicits Endothelial Dysfunction and Atherosclerosis Formation via Inhibiting De-Sumoylation Enzyme SENP2 (2013) (0)
- Loss of SUMO-specific protease 2 causes isolated glucocorticoid deficiency by blocking adrenal cortex zonal transdifferentiation in mice (2022) (0)
- Cardiac dysrhythmia in the cancer patient (2003) (0)
- Microphthalmia‐associated transcription factor, melanoma, and renal carcinoma: the small ubiquitin‐like modifier connection (2011) (0)
- patients & modify CV risk factors Strategies for reducing cardiotoxicity : Anthracycline : Dose reduction , continuous infusion , liposomal doxorubicin , dexrazoxane Trastuzumab : Avoid concomitant anthracycline VSP inhibitors : Treat hypertension (0)
- Chapter 8 – Chemotherapy-Induced Cardiomyopathy (2016) (0)
- Loss of SUMO-specific protease 2 causes isolated glucocorticoid deficiency by blocking zonal transdifferentiation (2022) (0)
- The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels (2021) (0)
- Mechanism and Prevention of Cardiomyopathy Due to Chemotherapy (2018) (0)
- Tanks to the Reviewers (2005) (0)
- Obesity, Inflammation, and Vascular Disease: Novel Insight in the Role of Adipose Tissue (2013) (0)
- Kaposi’s Sarcoma-Associated Herpesvirus K-bZIP Represses Gene Transcription via SUMO Modification (2005) (0)
- Abolition of coronary thrombosis by local application of an E-, P-, and L-selectin inhibitor (1996) (0)
- TNF-induced afoptosis is mediated through inhibition of mitochondrial respiration chain complex I (1996) (0)
- Adult progenitor cells for cardiac repair: preclinical studies. (2009) (0)
- Evaluation of the cardiovascular system in the cancer patient (2003) (0)
- Abstract 17234: Comparing the Efficacy of Primary Prevention Strategies in Doxorubicin-induced Cardiotoxicity using Echocardiography and High-Sensitivity Troponin T (2014) (0)
- Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway (2018) (0)
- Hybridoma Stimulation and IL-2 Assay (2003) (0)
- SENP3 and SENP5 Peptidases (2013) (0)
- Cardiovascular risk associated with androgen deprivation therapy. (2010) (0)
- Macrophage homing to atherosclerotic plaques in apo-E deficient mice is inhibited by anti-ICAM-1, but not by anti-E-selectin MAb (1998) (0)
- Contents Vol. 42, 2005 (2005) (0)
- 1 Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin-Cytosine Deaminase-Uracil Phosphoribosyl Transferase (2011) (0)
- Abstract 14415: The Sumo Protease Senp2 Regulates Endothelial Dysfunction and Subsequent Atherosclerosis Formation (2012) (0)
- Fusion of Human Hematopoietic Progenitor Cells and Murine Cardiomyocytes Is Mediated by (cid:1) 4 (cid:2) 1 Integrin/Vascular Cell Adhesion Molecule-1 Interaction (2007) (0)
- C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation. Authors' reply (2003) (0)
- Dependence of Acute Myeloid Leukemia Development on Membrane Protein Dipeptidyl Peptidase 4 (2022) (0)
- Metastatic involvement of cardiac structures (2003) (0)
- Structural Characterization of the TAP Molecu Phosphatidylinositol-linked Glycoprotein Distinc ram the T Cell Receptor/T3 (=omplex and T (2003) (0)
- Can Medications Be Safely Withdrawn in Patients With Chemotherapy-induced Heart Failure With Recovered Heart Function? (2014) (0)
- Physiological Mechanisms of Atrially Induced Heart Rate Turbulence (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edward T. H. Yeh?
Edward T. H. Yeh is affiliated with the following schools:
